Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 9;9(10):e1154. doi: 10.1002/cti2.1154

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

CT imaging of the mediastinal window of the patient. The results obtained on four representative days are shown. (a) Day −12 before the patient was administered CAR‐T cells: maximum tumor diameter, 78.6 mm; (b) Day +29, that is when the patient came for the first follow‐up: the maximum tumor diameter, 73.3 mm (indicating stable disease [SD]); (c) Day +49, that is 2 days after the patient was admitted because of ALL/ARDS and respiratory failure: maximum tumor diameter, 70.2 mm (SD); (d) Day +64, that is when the patient recovered from ALI/ARDS: maximum tumor diameter, 72.8 mm.